Do FSH (Follicle-Stimulating Hormone) and LH (Luteinizing Hormone) lab tests need to be collected at a certain time?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

FSH and LH Testing: Timing Requirements

For most clinical indications, FSH and LH should be collected in the morning (around 8 AM) to optimize accuracy, particularly for gonadotropin measurements, though the specific day of the menstrual cycle is more critical than time of day for menstruating women. 1

Timing Considerations by Clinical Context

Time of Day Requirements

  • Morning collection (around 8 AM) is critical for accurate interpretation of hormone levels, particularly when assessing the hypothalamic-pituitary-gonadal axis, as this timing optimizes gonadotropin and sex hormone measurements 1
  • Morning sampling is especially important when evaluating for hypogonadism, as testosterone levels show significant diurnal variation and should be taken in the morning 2
  • For patients on immunotherapy or with suspected pituitary dysfunction, morning collection ensures optimal assessment of FSH, LH, and other pituitary hormones 1

Menstrual Cycle Timing (For Menstruating Women)

  • FSH and LH should be collected during the early follicular phase (days 2-5 of the menstrual cycle) for baseline assessment 2, 3
  • Mid-follicular phase sampling (around day 6) can be used to assess progressive changes in gonadotropin levels 4
  • The timing within the menstrual cycle is more critical than time of day for menstruating women, as FSH and LH levels vary dramatically throughout the cycle 5
  • A mid-cycle LH peak is a laboratory criterion for normal ovulatory cycles, so timing relative to ovulation matters for specific indications 5

Special Clinical Situations

For hypogonadism evaluation:

  • In premenopausal women with menstrual irregularity or evidence of hypogonadism, FSH, LH, and estradiol should be assessed together to distinguish primary from secondary hypogonadism 2, 1
  • Low gonadotropins with low sex hormones indicate central (pituitary) dysfunction, while high gonadotropins with low sex hormones indicate primary gonadal failure 1

For polycystic ovary syndrome (PCOS) diagnosis:

  • FSH and LH should be measured in the follicular phase, as an LH to FSH ratio >2 is characteristic of PCOS 2
  • In functional hypothalamic amenorrhea (FHA), the LH to FSH ratio is typically <1 in about 82% of patients 2

For fertility treatment monitoring:

  • Sequential LH measurements may be used to time ovulation during artificial insemination or in vitro fertilization programs 3
  • During ovulation induction therapy, FSH and LH can be monitored on alternate days to assess response 6

Common Pitfalls and Caveats

  • Avoid single time-point measurements when investigating reproductive disorders, as sampling at only one time of day or one point in the cycle can lead to incorrect conclusions 2
  • Do not collect samples during or immediately after corticosteroid administration when evaluating for hypophysitis, as steroids suppress the hypothalamic-pituitary axis and confound results 1
  • For postmenopausal women or men, cycle timing is irrelevant, but morning collection remains optimal 2, 1
  • Serum is preferred to plasma and should be stored frozen before assay if not processed immediately 3
  • No special preservatives are needed for sample collection 3

References

Guideline

Hormone Testing in Clinical Practice

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Measurement of serum levels of exogenously administered FSH and LH during ovulation induction therapy.

Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.